Contact information
Jennifer Williams
BSc (Hons), PhD
Senior Clinical Research Manager
I am based within the Experimental Medicine and Rheumatology group of OCTRU. I facilitate clinical translation within the Kennedy Institute of Rheumatology by working with Principal Investigators to develop proposals for new experimental medicine studies and clinical trials. I also support the existing trial portfolio within the Kennedy Institute.
I joined NDORMS in 2018 as a trial manager working on experimental medicine and rheumatology studies, HOPE-e, RAMBOH-1 and VROOM.
Prior to joining NDORMS I was part of the NIHR Clinical Research Network facilitating the set-up and running of several commercial CTIMPs.
Before moving into the field of clinical trials, I was a scientist working in lab-based research for over 10 years. I gained my BSc (Hons) from the University of Birmingham after which I moved to London and gained my PhD in Cell Biology from UCL Institute of Ophthalmology. The majority of my publications focus on the role of the complement system in age-related macular degeneration.
Recent publications
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek A. et al, (2024), Lancet rheumatol, 6, e92 - e104
-
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
Williams JAE. et al, (2022), Lancet rheumatol, 4, e725 - e737
-
HAND OSTEOARTHRITIS: INVESTIGATING PAIN EFFECTS IN A RANDOMISED PLACEBO-CONTROLLED FEASIBILITY STUDY OF ESTROGEN-CONTAINING THERAPY (HOPE-E): REPORT ON THE PRIMARY FEASIBILITY OUTCOMES
Williams JAE. et al, (2022), Annals of the rheumatic diseases, 81, 1616 - 1617
-
Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial.
Marian IR. et al, (2021), Pilot feasibility stud, 7